Author

D. Bogucki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Hasan· 1 shared A. Hussainkhel· 1 shared A. J. Cutts· 1 shared A. Lindgren· 1 shared A. Williams· 1 shared A. Zenova· 1 shared C. Dehnhardt· 1 shared C. Dube· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Hasan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NBI-921352, a First-in-Class, Na V 1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of- Function Mice, and Wild-Type Mice and Rats

J. Johnson, T. Focken, K. Khakh, P. K. Tari, C. Dube, A. Williams, J.-C. Andrez, G. Bankar, D. Bogucki, K. Burford, E. Chang, S. Chowdhury, R. Dean, G. de Boer, S. Decker, , W

This paper describes NBI-921352, a selective NaV1.6 inhibitor that prevents seizures in Scn8a gain-of-function mice and wild-type models, with better efficacy and tolerability than existing antiseizure drugs.

eLife · Mar 2, 2022Peer-reviewedPharmacology & Toxicology